Long-term keto diet triggers metabolic issues in mice

A new study from University of Utah Health reveals that while the ketogenic diet prevents weight gain in mice, it leads to serious metabolic problems like fatty liver disease and impaired blood sugar control over time. Male mice experienced the most severe effects, including liver damage. The findings, published in Science Advances, question the diet's long-term safety for metabolic health.

Researchers at University of Utah Health conducted a long-term experiment on adult male and female mice to assess the ketogenic diet's effects on metabolism. The mice followed one of four diets for nine months or more: a high-fat Western diet, a low-fat high-carbohydrate diet, a traditional ketogenic diet with nearly all calories from fat, or a protein-matched low-fat diet. Throughout the study, the team monitored body weight, food intake, blood lipids, liver fat accumulation, and blood sugar and insulin levels. They also analyzed gene activity in pancreatic cells and used microscopy to examine cellular changes.

Mice on the ketogenic diet gained significantly less weight than those on the Western diet, an effect observed in both sexes. However, any weight increase was primarily fat mass rather than lean tissue. Despite this benefit, the diet caused notable metabolic disruptions. Within days, excess fats accumulated in the blood and liver, leading to fatty liver disease—a marker of metabolic illness often tied to obesity.

"One thing that's very clear is that if you have a really high-fat diet, the lipids have to go somewhere, and they usually end up in the blood and the liver," said Amandine Chaix, PhD, assistant professor of nutrition and integrative physiology at University of Utah Health and senior author of the study. Male mice developed severe fatty liver disease and impaired liver function, while females showed no significant liver fat buildup. The researchers plan further investigation into this sex-based difference.

Blood sugar regulation also suffered. After two to three months, keto-fed mice had low blood sugar and insulin levels, but reintroducing carbohydrates caused dangerously prolonged high blood glucose spikes due to inadequate insulin release from stressed pancreatic cells. Chaix noted, "The problem is that when you then give these mice a little bit of carbs, their carb response is completely skewed... and that's quite dangerous."

Encouragingly, blood sugar control improved after removing the mice from the diet, indicating some reversibility. The study, titled "A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice," appears in Science Advances (2025; 11(38)). Lead author Molly Gallop, PhD, emphasized the gap in prior research: "We've seen short-term studies and those just looking at weight, but not really any studies looking at what happens over the longer term or with other facets of metabolic health."

Though conducted in mice, the results highlight potential risks for humans using the diet for weight loss or managing obesity and type 2 diabetes. Gallop advised, "I would urge anyone to talk to a health care provider if they're thinking about going on a ketogenic diet."

Relaterede artikler

Realistic illustration of mouse gut microbiome metabolites traveling to liver, impacting energy and insulin for obesity-diabetes research.
Billede genereret af AI

Harvard-led study maps gut metabolites that may shape obesity and diabetes risk

Rapporteret af AI Billede genereret af AI Faktatjekket

Researchers working at Harvard University and collaborators in Brazil have identified metabolites produced by gut bacteria that travel through the portal vein to the liver and appear to influence energy use and insulin sensitivity in mice. The findings, published in Cell Metabolism, suggest possible new strategies for preventing or treating obesity and type 2 diabetes by targeting gut–liver communication.([sciencedaily.com](https://www.sciencedaily.com/releases/2025/12/251214100926.htm?utm_source=openai))

A new study shows that a high-fat ketogenic diet can normalize blood sugar levels in mice with hyperglycemia and enhance their muscles' response to exercise. Led by researcher Sarah Lessard, the research indicates that combining the diet with physical activity leads to better oxygen use and endurance. The findings suggest potential benefits for metabolic health when diet and exercise are paired.

Rapporteret af AI

New research from MIT demonstrates that prolonged high-fat diets push liver cells into a primitive state, increasing their vulnerability to cancer. By analyzing mice and human samples, scientists uncovered how these cellular changes prioritize survival over normal function, paving the way for tumors. The findings, published in Cell, highlight potential drug targets to mitigate this risk.

Researchers at the University of Adelaide have found that blocking the enzyme Caspase-2, previously seen as a potential treatment for fatty liver disease, may increase the risk of chronic liver damage and cancer over time. In genetically modified mice lacking functional Caspase-2, liver cells grew abnormally large and accumulated genetic damage, leading to inflammation, scarring, and tumors. The findings, published in Science Advances, challenge the development of Caspase-2 inhibitors.

Rapporteret af AI

A new Cochrane review of 22 clinical trials shows that intermittent fasting does not lead to greater weight loss than standard diet advice for overweight or obese adults. The analysis, involving nearly 2,000 participants, challenges the popularity of fasting methods amid rising global obesity rates. Researchers emphasize the need for more long-term studies and personalized approaches.

An extract from Nitraria roborowskii, a desert shrub used in traditional Chinese medicine, improved insulin sensitivity and metabolic markers in diabetic mice by reactivating the PI3K/AKT pathway, according to a peer‑reviewed study in the Chinese Journal of Modern Applied Pharmacy and a summary posted on ScienceDaily.

Rapporteret af AI

Researchers have identified why living at high altitudes reduces diabetes risk: red blood cells absorb excess glucose in low-oxygen conditions. This metabolic shift lowers blood sugar levels, as shown in mouse experiments. A new drug mimicking this effect reversed diabetes in mice, suggesting potential treatments.

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis